Mehr lesen
Informationen zum Autor PRABODH MALHOTRA was born and brought up in India but has been living in Australia since 1980. Thus, he understands both systems. He has taught at a number of universities in Australia. Prabodh has PhD in Economics and Masters in International Business and has published conference papers, journal articles and government reports in these areas. This book is based on his extensive research and fieldwork in India. Klappentext In India today only 35 percent of people have access to medicines. This book examines the rise of drug prices in India, and develops a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable Zusammenfassung In India today only 35 percent of people have access to medicines. This book examines the rise of drug prices in India, and develops a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable Inhaltsverzeichnis Foreword Acknowledgments Introduction PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES The World Trade Organization and the TRIPS Agreement The Global Pharmaceutical Industry and Developing New Drugs PART II: ACCESS TO MEDICINES IN INDIA Development of India's Pharmaceutical Industry TRIPS and the Indian Patents Regime Price Controls and Drug Affordability in India: Policy Options Health Insurance in India Broadening the Access to Medicines and Healthcare in India PART III: GLOBAL PERSPECTIVE Is TRIPS Appropriate for Developing Countries? Which Way Ahead? Final Conclusions References
Inhaltsverzeichnis
Foreword Acknowledgments Introduction PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES The World Trade Organization and the TRIPS Agreement The Global Pharmaceutical Industry and Developing New Drugs PART II: ACCESS TO MEDICINES IN INDIA Development of India's Pharmaceutical Industry TRIPS and the Indian Patents Regime Price Controls and Drug Affordability in India: Policy Options Health Insurance in India Broadening the Access to Medicines and Healthcare in India PART III: GLOBAL PERSPECTIVE Is TRIPS Appropriate for Developing Countries? Which Way Ahead? Final Conclusions References
